Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1230.7000 -5.60 (-0.45%)

NSE May 16, 2025 15:31 PM

Volume: 882.9K

Dr. Reddy's Laboratories Ltd.

20 May 2022

1230.70

-0.45%

Dr Reddy's Labs (HOLD): Operating performance in line; impairment weighs down profit

Hold: Dr. Reddy's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

India, Russia, US and one-off opportunities drove 15% YoY sales growth in Q4; non-core brands divested in Russia and India

Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr